Suchergebnisse
Suchergebnisse:
Hier sollte eine Beschreibung angezeigt werden, diese Seite lässt dies jedoch nicht zu.
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
- 75,000 (2021)
- US$20.248 Billion (Fiscal Year Ended September 30, 2021)
- East Rutherford, New Jersey (1897)
Company Info. Financial Info. Stock Data. SEC Filings. ESG. Governance. BD is advancing the world of health™️️. For over 125 years, BD has been advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care.
12. Nov. 2021 · FRANKLIN LAKES, N.J., Nov. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to...
BD Issues 2021 ESG Report. July 05, 2022 6:55 am EDT Download as PDF. Company makes notable progress toward 2030+ ESG commitments, addressing energy, water and waste reduction, environmental impact of product portfolio and supplier diversification. FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ...
FRANKLIN LAKES, N.J., Nov. 5, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020. This represents an increase of 4.4% over the prior-year period on both a reported and ...
Becton, Dickinson and Company (BD), has issued a series of recalls for different models and modules of its Alaris System, consisting of infusion and IV systems and software, with four recalls announced this year alone. The BD Alaris line of products was first approved by the FDA in 1995, with many different models subsequently approved. Many of ...
